Type-2 diabetes, which has dramatically spread in the last decade, is most often associated with being overweight and suffering from obesity.

European researchers have designed two new vaccine candidates to fight the HIV virus. These have been developed within the EU-funded project EURONEUT 41 .

AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41 , is based on one of the envelope proteins of the HIV virus , called the gp41 protein.

Mona Elena Popa, is Professor of industrial biotechnology at the  University of Agronomical Sciences and Veterinary Medicine of Bucharest  in Romania. She talks to youris.